Samsara Bio Capital, LLC Nkarta, Inc. Transaction History
Samsara Bio Capital, LLC
- $217 Million
- Q1 2025
A detailed history of Samsara Bio Capital, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 3,768,035 shares of NKTX stock, worth $6.59 Million. This represents 3.2% of its overall portfolio holdings.
Number of Shares
3,768,035
Previous 3,768,035
-0.0%
Holding current value
$6.59 Million
Previous $9.38 Million
26.1%
% of portfolio
3.2%
Previous 2.88%
Shares
5 transactions
Others Institutions Holding NKTX
# of Institutions
118Shares Held
61MCall Options Held
13.7KPut Options Held
10.3K-
Ra Capital Management, L.P. Boston, MA10.8MShares$18.9 Million0.41% of portfolio
-
Tang Capital Management LLC San Diego, CA7.06MShares$12.3 Million0.84% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$7.1 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$6.25 Million0.62% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.51MShares$6.14 Million0.0% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $85.1M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...